Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
Ontology highlight
ABSTRACT: Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
PROVIDER: PRJNA1006073 | ENA |
REPOSITORIES: ENA
ACCESS DATA